Herbert Wettreich, MD
Otolaryngology · Mooresville, NCNPI 1215008545
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 27.7% of the total. Reporting peaked in 2022 at $2,708 and has fallen 88.8% since, to $303 in 2025.
Across 78 payments — averaging $65.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Medical Device Business Services, Inc.$1K
- Acclarent, Inc$1K
- Sanofi$408
- GSK$205
- Stryker$136
- plus $301 from 11 others
What the payments were for
- Consulting fees$1,17023%
- Travel & lodging$2,33345%
- Food & beverage$1,62732%
- Gifts$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $1,424 |
| Medical Device Business Services, Inc. | 7 | $1,384 |
| Acclarent, Inc | 8 | $1,275 |
| Sanofi | 15 | $408 |
| GSK | 9 | $205 |
| Stryker | 7 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Integra Lifesciences Corporation | 2 | $32 |
| Smith+Nephew | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Preceptis Medical, Inc. | 1 | $21 |
| Alk-abello, Inc | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Optinose US, Inc. | 1 | $16 |
| Aerin Medical Inc. | 1 | $15 |
| Intersect ENT, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,132 in reported general payments places this provider in the 85th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 14 | $5,034 |
| Fluticasone Propionate | 95 | $2,192 |
| Cevimeline Hcl | 13 | $1,805 |
| Ipratropium Bromide | 35 | $1,145 |
| Famotidine | 68 | $1,139 |
| Azelastine Hcl | 36 | $913 |
| Sucralfate | 27 | $679 |
| Pantoprazole Sodium | 54 | $622 |
| Omeprazole | 28 | $433 |
| Mupirocin | 21 | $301 |
| Ofloxacin | 19 | $267 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $235 |
| Montelukast Sodium | 16 | $227 |
| Cefdinir | 11 | $188 |
| Doxycycline Hyclate | 24 | $181 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Mooresville
- Roy LewisMooresville$18K
- David JangDurham$324K
- Robert FerrisRaleigh$258K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Adam CampbellWinston Salem$47K
- Harold PillsburyChapel Hill$42K
- John BuentingSylva$30K
- Brendan O ConnellCharlotte$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.